The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fermentation Engineering for Pharmaceutical Drugs Market Research Report 2025
Synopsis
Fermentation is a process used for cultivating micro-organisms or other organic material into important pharmaceuticals such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
The global Fermentation Engineering for Pharmaceutical Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
This report aims to provide a comprehensive presentation of the global market for Fermentation Engineering for Pharmaceutical Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fermentation Engineering for Pharmaceutical Drugs.
Report Scope
The Fermentation Engineering for Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fermentation Engineering for Pharmaceutical Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fermentation Engineering for Pharmaceutical Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Segment by Type
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fermentation Engineering for Pharmaceutical Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fermentation is a process used for cultivating micro-organisms or other organic material into important pharmaceuticals such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
The global Fermentation Engineering for Pharmaceutical Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
This report aims to provide a comprehensive presentation of the global market for Fermentation Engineering for Pharmaceutical Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fermentation Engineering for Pharmaceutical Drugs.
Report Scope
The Fermentation Engineering for Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fermentation Engineering for Pharmaceutical Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fermentation Engineering for Pharmaceutical Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Segment by Type
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fermentation Engineering for Pharmaceutical Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fermentation Engineering for Pharmaceutical Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Antibiotic
1.2.4 Insulin
1.2.5 Human Growth Hormone
1.2.6 Pharmaceutical Amino Acids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Fermentation Engineering for Pharmaceutical Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fermentation Engineering for Pharmaceutical Drugs Market Perspective (2019-2030)
2.2 Fermentation Engineering for Pharmaceutical Drugs Growth Trends by Region
2.2.1 Global Fermentation Engineering for Pharmaceutical Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fermentation Engineering for Pharmaceutical Drugs Historic Market Size by Region (2019-2024)
2.2.3 Fermentation Engineering for Pharmaceutical Drugs Forecasted Market Size by Region (2025-2030)
2.3 Fermentation Engineering for Pharmaceutical Drugs Market Dynamics
2.3.1 Fermentation Engineering for Pharmaceutical Drugs Industry Trends
2.3.2 Fermentation Engineering for Pharmaceutical Drugs Market Drivers
2.3.3 Fermentation Engineering for Pharmaceutical Drugs Market Challenges
2.3.4 Fermentation Engineering for Pharmaceutical Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fermentation Engineering for Pharmaceutical Drugs Players by Revenue
3.1.1 Global Top Fermentation Engineering for Pharmaceutical Drugs Players by Revenue (2019-2024)
3.1.2 Global Fermentation Engineering for Pharmaceutical Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Fermentation Engineering for Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fermentation Engineering for Pharmaceutical Drugs Revenue
3.4 Global Fermentation Engineering for Pharmaceutical Drugs Market Concentration Ratio
3.4.1 Global Fermentation Engineering for Pharmaceutical Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fermentation Engineering for Pharmaceutical Drugs Revenue in 2023
3.5 Fermentation Engineering for Pharmaceutical Drugs Key Players Head office and Area Served
3.6 Key Players Fermentation Engineering for Pharmaceutical Drugs Product Solution and Service
3.7 Date of Enter into Fermentation Engineering for Pharmaceutical Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fermentation Engineering for Pharmaceutical Drugs Breakdown Data by Type
4.1 Global Fermentation Engineering for Pharmaceutical Drugs Historic Market Size by Type (2019-2024)
4.2 Global Fermentation Engineering for Pharmaceutical Drugs Forecasted Market Size by Type (2025-2030)
5 Fermentation Engineering for Pharmaceutical Drugs Breakdown Data by Application
5.1 Global Fermentation Engineering for Pharmaceutical Drugs Historic Market Size by Application (2019-2024)
5.2 Global Fermentation Engineering for Pharmaceutical Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fermentation Engineering for Pharmaceutical Drugs Market Size (2019-2030)
6.2 North America Fermentation Engineering for Pharmaceutical Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2019-2024)
6.4 North America Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fermentation Engineering for Pharmaceutical Drugs Market Size (2019-2030)
7.2 Europe Fermentation Engineering for Pharmaceutical Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2019-2024)
7.4 Europe Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs Market Size (2019-2030)
8.2 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Fermentation Engineering for Pharmaceutical Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fermentation Engineering for Pharmaceutical Drugs Market Size (2019-2030)
9.2 Latin America Fermentation Engineering for Pharmaceutical Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2019-2024)
9.4 Latin America Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Market Size (2019-2030)
10.2 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Changchun GeneScience Pharmaceutical
11.1.1 Changchun GeneScience Pharmaceutical Company Detail
11.1.2 Changchun GeneScience Pharmaceutical Business Overview
11.1.3 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.1.4 Changchun GeneScience Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.1.5 Changchun GeneScience Pharmaceutical Recent Development
11.2 3SBio Inc
11.2.1 3SBio Inc Company Detail
11.2.2 3SBio Inc Business Overview
11.2.3 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Introduction
11.2.4 3SBio Inc Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.2.5 3SBio Inc Recent Development
11.3 Shanghai Fosun Pharmaceutical
11.3.1 Shanghai Fosun Pharmaceutical Company Detail
11.3.2 Shanghai Fosun Pharmaceutical Business Overview
11.3.3 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.3.4 Shanghai Fosun Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.3.5 Shanghai Fosun Pharmaceutical Recent Development
11.4 Sichuan Kelun Pharmaceutical
11.4.1 Sichuan Kelun Pharmaceutical Company Detail
11.4.2 Sichuan Kelun Pharmaceutical Business Overview
11.4.3 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.4.4 Sichuan Kelun Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.4.5 Sichuan Kelun Pharmaceutical Recent Development
11.5 Shanghai Shyndec Pharmaceutical
11.5.1 Shanghai Shyndec Pharmaceutical Company Detail
11.5.2 Shanghai Shyndec Pharmaceutical Business Overview
11.5.3 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.5.4 Shanghai Shyndec Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.5.5 Shanghai Shyndec Pharmaceutical Recent Development
11.6 CSPC Pharmaceutical Group
11.6.1 CSPC Pharmaceutical Group Company Detail
11.6.2 CSPC Pharmaceutical Group Business Overview
11.6.3 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction
11.6.4 CSPC Pharmaceutical Group Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.6.5 CSPC Pharmaceutical Group Recent Development
11.7 United Laboratories International Holdings
11.7.1 United Laboratories International Holdings Company Detail
11.7.2 United Laboratories International Holdings Business Overview
11.7.3 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Introduction
11.7.4 United Laboratories International Holdings Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.7.5 United Laboratories International Holdings Recent Development
11.8 Tonghua Dongbao Pharmaceutical
11.8.1 Tonghua Dongbao Pharmaceutical Company Detail
11.8.2 Tonghua Dongbao Pharmaceutical Business Overview
11.8.3 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Introduction
11.8.4 Tonghua Dongbao Pharmaceutical Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.8.5 Tonghua Dongbao Pharmaceutical Recent Development
11.9 Joincare Pharmaceutical Group
11.9.1 Joincare Pharmaceutical Group Company Detail
11.9.2 Joincare Pharmaceutical Group Business Overview
11.9.3 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction
11.9.4 Joincare Pharmaceutical Group Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.9.5 Joincare Pharmaceutical Group Recent Development
11.10 North China Pharma
11.10.1 North China Pharma Company Detail
11.10.2 North China Pharma Business Overview
11.10.3 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Introduction
11.10.4 North China Pharma Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.10.5 North China Pharma Recent Development
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Company Detail
11.11.2 Anhui Anke Biotechnology Business Overview
11.11.3 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Introduction
11.11.4 Anhui Anke Biotechnology Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.11.5 Anhui Anke Biotechnology Recent Development
11.12 Gan and Lee Pharmaceuticals
11.12.1 Gan and Lee Pharmaceuticals Company Detail
11.12.2 Gan and Lee Pharmaceuticals Business Overview
11.12.3 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Introduction
11.12.4 Gan and Lee Pharmaceuticals Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.12.5 Gan and Lee Pharmaceuticals Recent Development
11.13 Shandong Kexing Bioproducts
11.13.1 Shandong Kexing Bioproducts Company Detail
11.13.2 Shandong Kexing Bioproducts Business Overview
11.13.3 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Introduction
11.13.4 Shandong Kexing Bioproducts Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.13.5 Shandong Kexing Bioproducts Recent Development
11.14 Harbin Pharmaceutical Group
11.14.1 Harbin Pharmaceutical Group Company Detail
11.14.2 Harbin Pharmaceutical Group Business Overview
11.14.3 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Introduction
11.14.4 Harbin Pharmaceutical Group Revenue in Fermentation Engineering for Pharmaceutical Drugs Business (2019-2024)
11.14.5 Harbin Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
